The chair of a board advising on the legalisation of psychedelic mushrooms in Oregon has resigned after being accused of standing to profit financially from the potentially $1bn industry he is helping to shape.
In 2020, after a landmark US-first vote, Oregon legalized the therapeutic use of psilocybin. But the ructions at the board could throw the whole industry into disarray.